Institutional Ownership
Quince Therapeutics Inc
CUSIP 22053A107COMQNCXQ1 2026
13D / 13G Filings
38
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
10.7%
Max % of class reported
Institutional Holders
37
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
38 filings · latest Mar 5, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 5, 2026 | Group One Trading LLC | 13G | 10.7% | 5.94M | SEC |
| 2 | Nov 14, 2025 | Nantahala Capital Management, LLC | 13G/A | 10.0% | 5.62M | SEC |
| 3 | Oct 30, 2025 | Genextra S.P.A. | 13G/A | — | — | SEC |
| 4 | Aug 14, 2025 | Nantahala Capital Management, LLC | 13G | 10.0% | 4.77M | SEC |
| 5 | Apr 30, 2025 | Sofinnova Capital Viii | 13G/A | 2.7% | 1.20M | SEC |
| 6 | Feb 18, 2025 | Genextra S.P.A. | 13G/A | 6.5% | 2.81M | SEC |
| 7 | Feb 14, 2025 | Sofinnova Capital Viii | 13G | 5.4% | 2.40M | SEC |
| 8 | Nov 14, 2024 | Tang Capital Management LLC | 13G/A | — | — | SEC |
| 9 | Nov 13, 2024 | Lamond David | 13D | 10.1% | 4.46M | SEC |
| 10 | Aug 6, 2024 | Sofinnova Partners Sas | 13G/A | 5.0% | 2.16M | SEC |
28 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Quince Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Woodline Partners LP | 5.20M | $527.3K |
| 2 | Millennium Management LLC | 2.50M | $253.9K |
| 3 | Shay Capital LLC | 1.77M | $179.8K |
| 4 | Ieq Capital, LLC | 600.1K | $60.9K |
| 5 | Blackrock, Inc. | 473.3K | $48.0K |
| 6 | State Street Corp | 248.0K | $25.1K |
| 7 | Susquehanna International Group, LLP | 172.6K | $17.5K |
| 8 | Simplex Trading, LLC | 154.1K | $15.6K |
| 9 | Vanguard Personalized Indexing Management, LLC | 132.7K | $13.5K |
| 10 | Two Sigma Investments, LP | 71.2K | $7.2K |